Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 053030270 approvals39 trials

Binex Co., Ltd.

Official website

Founded in 1985 and listed on KOSDAQ in 2001, Binex is a chemical pharmaceutical and biopharmaceutical CDMO company.

Price

Change

Market cap

Products & technology

  • AntidiarrhealGastrointestinal treatment
  • Eye dropsOphthalmic solution
  • Biopharmaceutical CDMO serviceCell line development, process development, GMP drug substance and drug product manufacturing

Regulatory approvals

data.go.kr

270 Korean MFDS drug approvals · 1979–2026

  • MFDS drugTwinspin-S Tab. 40/2.5mg2026-07-28
    Drug · Prescription · Approval202602173
  • MFDS drugTwinspin-S Tab. 40/5mg2026-07-28
    Drug · Prescription · Approval202602174
  • MFDS drugTwinspin-S Tab. 80/2.5mg2026-07-28
    Drug · Prescription · Approval202602175
  • MFDS drugTwinspin-S Tab. 80/5mg2026-07-28
    Drug · Prescription · Approval202602176
  • MFDS drugPitanex Tab. 1mg2026-06-29
    Drug · Prescription · Approval202601830
  • MFDS drugIbron Syr.2026-04-14
    Drug · OTC · Notification202601084
  • MFDS drugCitu-care Tab 50mg (Pranlukast Hydrate)2026-01-30
    Drug · Prescription · Approval202600277
  • MFDS drugBiscan Pro-duo Cap.2025-07-24
    Drug · OTC · Notification202501886
  • MFDS drugPitanewfen Cap.2025-07-11
    Drug · Prescription · Approval202501756
  • MFDS drugProbiomeC Cap.2025-03-20
    Drug · OTC · Notification202500636
  • MFDS drugFlora7 Cap.2025-03-20
    Drug · OTC · Notification202500637
  • MFDS drugCit-Q Tab.2025-03-18
    Drug · OTC · Notification202500603
Show 68 more
  • MFDS drugBromferine Eye Drops(Bromfenac Sodium Hydrate)(Single use)2024-10-28
    Drug · Prescription · Approval202402538
  • MFDS drugGinkgobila Tab. 240mg2024-08-28
    Drug · OTC · Notification202402078
  • MFDS drugDimenceline Tab. 30mg2024-06-24
    Drug · Prescription · Approval202401520
  • MFDS drugJamein Tab.2024-01-16
    Drug · OTC · Notification202400104
  • MFDS drugMarothin Tab.2023-12-18
    Drug · OTC · Notification202303360
  • MFDS drugBiscan-B Cap.2023-09-22
    Drug · OTC · Notification202302804
  • MFDS drugBiscan-B Pow.2023-09-15
    Drug · OTC · Notification202302766
  • MFDS drugLukalevo Tab.2023-08-25
    Drug · Prescription · Approval202302518
  • MFDS drugProB7 Pow.2023-07-24
    Drug · OTC · Notification202302223
  • MFDS drugProB7 Cap.2023-07-24
    Drug · OTC · Notification202302230
  • MFDS drugNune Fresh Eye Drops 1.0% (single use)2023-06-07
    Drug · OTC · Notification202301765
  • MFDS drugDapoxi Tab. 10mg2023-01-16
    Drug · Prescription · Approval202300256
  • MFDS drugFimalopine Tab. 30/2.5mg2023-01-06
    Drug · Prescription · Approval202300084
  • MFDS drugFimalopine Tab. 60/5mg2023-01-06
    Drug · Prescription · Approval202300099
  • MFDS drugFimalopine Tab. 60/2.5mg2023-01-06
    Drug · Prescription · Approval202300126
  • MFDS drugDamet XR Tab. 5/500mg2022-11-10
    Drug · Prescription · Approval202204073
  • MFDS drugDamet XR Tab. 10/500mgRevoked2022-11-10
    Drug · Prescription · Approval202204074
  • MFDS drugAlepro Eye Drops 0.7% (single use)2022-08-03
    Drug · Prescription · Approval202203178
  • MFDS drugDoxic Tab.50mg2022-06-30
    Drug · Prescription · Approval202202687
  • MFDS drugTineglip M SR Tab. 20/1000mg2022-04-04
    Drug · Prescription · Approval202201420
  • MFDS drugTineglip M SR Tab. 10/750mg2022-04-04
    Drug · Prescription · Approval202201421
  • MFDS drugTineglip M SR Tab. 10/500mg2022-04-04
    Drug · Prescription · Approval202201422
  • MFDS drugNexgliptinduo Tab. 50/1000mg2022-01-06
    Drug · Prescription · Approval202200117
  • MFDS drugNexgliptinduo Tab. 50/500mg2022-01-06
    Drug · Prescription · Approval202200118
  • MFDS drugNexgliptinduo Tab. 50/850mg2022-01-06
    Drug · Prescription · Approval202200119
  • MFDS drugForxivia Tab. 10/100mg2022-01-04
    Drug · Prescription · Approval202200051
  • MFDS drugEso-oh Tab. 20/800mg2021-11-10
    Drug · Prescription · Approval202107426
  • MFDS drugDamet XR Tab. 10/1000mg2021-10-13
    Drug · Prescription · Approval202106882
  • MFDS drugDamet XR Tab. 5/1000mg2021-10-13
    Drug · Prescription · Approval202106883
  • MFDS drugBi-Tofacitinib Tab. 5mgRevoked2021-02-05
    Drug · Prescription · Approval202101128
  • MFDS drugTineglip Tab. 20mg2021-02-02
    Drug · Prescription · Approval202101004
  • MFDS drugDITUIN B Tab.Revoked2020-10-29
    Drug · OTC · Notification202007412
  • MFDS drugRimotec tab. 100mgRevoked2020-08-13
    Drug · OTC · Notification202005794
  • MFDS drugNexgliptin Tab. 100mg2020-08-03
    Drug · Prescription · Approval202005610
  • MFDS drugNexgliptin Tab. 50mg2020-08-03
    Drug · Prescription · Approval202005611
  • MFDS drugNexgliptin Tab. 25mg2020-08-03
    Drug · Prescription · Approval202005612
  • MFDS drugArtifosol eye drops 3% (disposable)2020-06-29
    Drug · Prescription · Approval202004705
  • MFDS drugLevotra eye drops 1.5%2020-06-29
    Drug · Prescription · Approval202004754
  • MFDS drugMonospinplus Tab. 40/12.5mgRevoked2020-06-11
    Drug · Prescription · Approval202004333
  • MFDS drugMonospinplus Tab. 80/12.5mgRevoked2020-06-11
    Drug · Prescription · Approval202004334
  • MFDS drugEpinys Tab.Revoked2020-05-13
    Drug · Prescription · Approval202003467
  • MFDS drugPolamac Tab.Revoked2020-04-23
    Drug · Prescription · Approval202002932
  • MFDS drugBinex tamsulosinHCl SR Tab. 0.4mg2020-04-17
    Drug · Prescription · Approval202002734
  • MFDS drugAnfera Cap.2020-02-28
    Drug · OTC · Notification202001421
  • MFDS drugLinatra duo tab. 2.5/1000mg2020-02-24
    Drug · Prescription · Approval202001309
  • MFDS drugLinatra duo tab. 2.5/850mg2020-02-24
    Drug · Prescription · Approval202001310
  • MFDS drugLinatra duo tab. 2.5/500mg2020-02-24
    Drug · Prescription · Approval202001311
  • MFDS drugTialduo Tab. 40/20mgRevoked2020-02-19
    Drug · Prescription · Approval202001159
  • MFDS drugTialduo Tab. 80/20mgRevoked2020-02-19
    Drug · Prescription · Approval202001160
  • MFDS drugMachpezil ODT Tab. 10mgRevoked2019-12-12
    Drug · Prescription · Approval201908363
  • MFDS drugMachpezil ODT Tab. 5mgRevoked2019-12-12
    Drug · Prescription · Approval201908364
  • MFDS drugBimo Tab.5mg2019-12-06
    Drug · Prescription · Notification201908280
  • MFDS drugThegainD Tab.2019-10-31
    Drug · OTC · Notification201907628
  • MFDS drugTirinta tab. 90mgRevoked2019-10-11
    Drug · Prescription · Approval201907179
  • MFDS drugTialduo Tab. 40/5mgRevoked2019-09-30
    Drug · Prescription · Approval201906976
  • MFDS drugTialduo Tab. 40/10mgRevoked2019-09-30
    Drug · Prescription · Approval201906977
  • MFDS drugTialduo Tab. 80/5mgRevoked2019-09-30
    Drug · Prescription · Approval201906978
  • MFDS drugTialduo Tab. 80/10mgRevoked2019-09-30
    Drug · Prescription · Approval201906979
  • MFDS drugTirinta tab. 60mgRevoked2019-09-19
    Drug · Prescription · Approval201906562
  • MFDS drugEmperisone SR Tab.2019-08-22
    Drug · Prescription · Approval201905950
  • MFDS drugLinatra Tab. 5mg2019-07-12
    Drug · Prescription · Approval201904712
  • MFDS drugCilovel SR Cap. 200mg2019-05-31
    Drug · Prescription · Approval201903653
  • MFDS drugCilovel SR Cap. 100mg2019-05-31
    Drug · Prescription · Approval201903654
  • MFDS drugSevitan HCT Tab. 5/20/12.5mgRevoked2019-05-31
    Drug · Prescription · Approval201903602
  • MFDS drugSevitan HCT Tab. 5/40/12.5mgRevoked2019-05-31
    Drug · Prescription · Approval201903603
  • MFDS drugEcathina Tab.Revoked2019-05-28
    Drug · OTC · Notification201903448
  • MFDS drugTheon Cap. 300mgRevoked2019-05-23
    Drug · Prescription · Notification201903350
  • MFDS drugDiart Cap.Revoked2019-05-16
    Drug · Prescription · Approval201903175

Showing the 80 most recent of 270 records.

Clinical trials

data.go.kr

39 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 39)

  • Bioequivalence모노스핀정80밀리그램(텔미사르탄)2026-01-20

    2 trial sites

  • Bioequivalence피타뉴젯정4/10밀리그램(피타바스타틴칼슘, 에제티미브)2025-04-30

    2 trial sites

  • Bioequivalence바이모정5밀리그램(미녹시딜)2024-02-06

    2 trial sites

  • Bioequivalence디멘세린정30밀리그램(니세르골린)2023-06-16

    2 trial sites

  • Bioequivalence펜트민정(펜터민염산염)2023-06-05

    2 trial sites

  • Bioequivalence펜디씬정(펜디메트라진타르타르산염)2023-06-01

    2 trial sites

  • Bioequivalence바이모정5밀리그램(미녹시딜)2023-05-08

    2 trial sites

  • Bioequivalence트윈스핀정40/5mg2022-06-02

    2 trial sites

  • Bioequivalence모노스핀정80밀리그램(텔미사르탄)2022-05-31

    2 trial sites

  • Bioequivalence바이넥스세파클러캡슐(세파클러수화물)2022-05-20

    2 trial sites

  • Bioequivalence피타넥스정(피타바스타틴칼슘)2022-02-15

    1 trial site

  • Bioequivalence다포시정10밀리그램(다파글리플로진프로판디올수화물)2022-02-15

    1 trial site

Show 27 more
  • Bioequivalence넥스라졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2022-02-09

    1 trial site

  • Bioequivalence트윈스핀정80/5mg2022-01-18

    1 trial site

  • Bioequivalence암로원정(암로디핀베실산염)2021-10-29

    2 trial sites

  • Bioequivalence바이피토정10밀리그램(아토르바스타틴칼슘삼수화물)2021-02-18

    2 trial sites

  • Bioequivalence바이넥스모니플루메이트정2020-12-30

    1 trial site

  • Bioequivalence로수넥스정10mg(로수바스타틴칼슘)2020-12-17

    2 trial sites

  • Bioequivalence독시크정50밀리그램(독시사이클린수화물)2020-07-31

    2 trial sites

  • Bioequivalence바이모틴정5밀리그램(모사프리드시트르산염수화물)2020-03-17

    2 trial sites

  • Bioequivalence독시크정50밀리그램(독시사이클린수화물)2018-04-20

    2 trial sites

  • Bioequivalence프레스타캡슐150밀리그램(프레가발린)2017-11-24

    2 trial sites

  • Bioequivalence펜디씬1/2정(펜디메트라진타르타르산염)2016-12-05

    2 trial sites

  • Bioequivalence프레스타캡슐150밀리그램(프레가발린)2016-04-29

    2 trial sites

  • Bioequivalence바이넥스티카그렐러정90밀리그램2015-09-14

    2 trial sites

  • Bioequivalence바이넥스탐스로신염산염정2015-06-18

    2 trial sites

  • Bioequivalence바이넥스칸데사르탄실렉세틸정16mg(가칭)2015-06-10

    2 trial sites

  • Bioequivalence바이피토정10밀리그램(아토르바스타틴칼슘)2015-06-02

    2 trial sites

  • Bioequivalence프레스타캡슐75밀리그램(프레가발린)2015-05-22

    2 trial sites

  • Bioequivalence로수넥스정10mg(로수바스타틴칼슘)2015-05-21

    2 trial sites

  • Bioequivalence바이넥스테노포비르디소프록실푸마르산염정(가칭)2015-05-20

    2 trial sites

  • Bioequivalence넥스라졸정40밀리그램(에스오메프라졸마그네슘이수화물)2015-05-20

    2 trial sites

  • Bioequivalence니찌이꼬란소프라졸구강붕해정30mg(가칭)2014-06-30

    2 trial sites

  • Bioequivalence펜디씬정(펜디메트라진타르타르산염)2014-05-09

    2 trial sites

  • Bioequivalence올메암로정 10/40밀리그램2013-09-02

    1 trial site

  • Bioequivalence라베넥스정20밀리그램(라베프라졸나트륨 20mg)2013-08-19

    2 trial sites

  • Bioequivalence바이넥스타다라필정(가칭)2013-03-20

    2 trial sites

  • Bioequivalence바이넥스로수바스타틴칼슘정(가칭)(로수바스타틴칼슘)2013-01-29

    2 trial sites

  • Bioequivalence토파씬정(토피라메이트)2012-07-20

    2 trial sites

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

HL GENOMICS Co., Ltd.85
Kolmar BioTech, Inc.85

Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition